Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from BioNTech

Breathtaking BioNTech Projections Reveal Revenue Rebound by 2025!

BioNTech envisions a bright future as it predicts a revival in revenue growth by 2025. Get ready for a thrilling comeback that will reshape the biotech lan...

Top News

Pfizer Sues Poland And Hungary Over Covid Debts

Pharmaceutical firms Pfizer and BioNTech are suing the governments of Poland and Hungary alleging they failed to pay for vaccines ordered during the Covid pandemic, lawyers said Tuesday.

International Business Times

UK will not return to Cameron era’s close ties with China, Sunak says

At summit to drum up foreign investment PM says he does not intend to change policy towards Beijing

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

University of Pennsylvania slammed for celebrating Nobel prize of vaccine researcher it once demoted

University once reportedly discouraged Katalin Karikó from pursuing mRNA research that later helped create Covid vaccines

The Independent UK

The trouble with a Nobel for mRNA COVID vaccines

The mRNA vaccine story during the COVID-19 pandemic placed an extraordinary premium on altruism on the part of scientists

The Hindu

The scientist whose research was key to developing the COVID vaccines was demoted, had her salary cut, and threatened with deportation. Today, she won the Nobel Prize

Katalin Karikó, now a vice-president at BioNTech, saw her research undermined for years before the 2005 breakthrough that led to the COVID-19 vaccine.

Fortune

Years of research laid the groundwork for speedy COVID-19 shots

The Nobel Prize in Medicine has been awarded to two scientists whose work led to mRNA vaccines against COVID-19

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Katalin Kariko, scientific maverick who paved way for mRNA vaccines

Katalin Kariko’s pioneering work -- which paved the way for the Pfizer/BioNTech and Moderna Covid-19 vaccines -- has won her the Nobel Prize in Medicine.

The Hindu

The Most Objective Evidence Shows No Indication That Covid Vaccines Save More Lives Than They Take

Medical journals describe all-cause mortality in randomized controlled trials (RCTs)

Zenger

Up to 10,000 Britons could take part in cancer vaccine trials

Participants could receive groundbreaking treatment after the Government signed an agreement with a leading pharmaceutical company.

The Independent UK

Moderna Stock Rises After FDA Application For Updated Vaccine

Moderna's potential beyond COVID-19 is underappreciated, says analyst Eliana Merle, who upgraded the stock to Buy

Zenger

Moderna (MRNA) vs. BioNTech (BNTX): Which Biotech Stock Should You Be Investing In?

Amidst the biotech industry’s rapid growth and notable advancements, let’s analyze which of the two major players, Moderna (MRNA) and BioNTech (BNTX), is a more favorable investment choice in the current uncertain economic climate. Keep reading to find out.

StockNews.com

‘Designing a vaccine that covers all cancers is hard’: biotech pioneer Lindy Durrant

The immunologist who runs Scancell is trialling novel treatments to attack tumours, as well as needle-free Covid jabs

The Guardian - UK

mRNA Vaccines Could Revolutionize Cancer Treatment

Here’s a look at the status of mRNA technology's application in cancer and when it might reach patients.

Inverse

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Ukraine, Sudan conflicts fuel alarming surge in tuberculosis

Top U.N. officials and health industry leaders are trying to tackle an alarming surge in tuberculosis, which is now killing more people worldwide than COVID-19 or AIDS

Asharq Al-Awsat

Pfizer, BioNTech Propose EU Pays Half for Each Cancelled COVID Dose

Pfizer Inc and BioNTech's new proposal to the European Union, amid a glut of COVID-19 shots, includes a provision for member states to pay half price, or about 10 euros ($11), for each of about 70 million cancelled doses, the Financial Times reported on Sunday. The revised contract would allow…

The Independent UK

‘Groundbreaking’ cancer and heart disease vaccine ‘could save millions of lives’

Experts hope new vaccines will be ready by end of decade

The Guardian - UK

‘A silver lining’: how Covid ushered in a vaccines golden era

Pandemic accelerated advances in vaccine technology, opening up possibilities for combating array of diseases

Get all your
news in one place.

100’s of premium titles.
One news app.

Radio France Internationale

Rwanda welcomes Africa's first mobile vaccine-production units

Six mobile vaccine-production units developed by German pharmaceutical company BioNTech have arrived in Rwanda. This is the first such shipment to Africa as the continent seeks to boost local production of mRNA vaccines.

The Conversation

What are these 'cancer vaccines' I'm hearing about? And what similarities do they share with COVID vaccines?

Barely a month goes by without headlines announcing yet another advancement in cancer vaccines.

The New Daily

What are these ‘cancer vaccines’ making news? Are there similarities with COVID vaccines?

Using the same mRNA technology as COVID vaccines, cancer vaccines are an emerging personalised treatment for cancer.

The Independent UK

Moderna, Pfizer and BioNTech Covid vaccine patent dispute heads to 2024 trial

US firm Moderna is suing its competitors for alleged patent infringement in relation to their Comirnaty vaccine.

Fortune

In synthetic biology, startups and incumbent companies should be partners, not foes

In this crucial area of innovation, established companies and startups must work together to deliver the benefits that the science promises.

The Guardian - UK

‘This will happen before 2030’: how the science behind Covid vaccines might help to fight cancer

The success of mRNA-based drugs in combating coronavirus is inspiring scientists to create similar vaccines for melanoma and other tumours

WEKU

At buzzy health care business conference, investors fear the bubble will burst

JPMorgan's cheery confab returned to San Francisco, but the health care capitalists had economic anxiety, too.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.